![Birger Jansson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Birger Jansson worked as Director of Research at Affibody AB, Vice President-Research & Development at CEPHEID, and Corporate VP-Research & Development at DiaSorin SpA from 2009 to 2011.
He holds a doctorate degree from the Royal Institute of Technology.
| Sociétés | Poste | Fin |
|---|---|---|
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Directeur Technique/Scientifique/R&D | - |
| DIASORIN S.P.A. | Directeur Technique/Scientifique/R&D | - |
| CEPHEID | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
CEPHEID
 CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
DiaSorin SpA
 DiaSorin SpA Medical SpecialtiesHealth Technology Specializes in research, production and sale of tests to identify pathogens in biological fluids | Health Technology |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
